Smokeless tobacco is associated with pathologic alterations of the oral mucosa, yet its direct effects on human keratinocytes and fibroblasts in stratified squamous epithelium are not well-understood. We hypothesized that smokeless tobacco could modulate the growth of keratinocytes and fibroblasts in an in vivo-like, organotypic tissue model. To test this, we exposed organotypic cultures for 3 days to smokeless tobacco aqueous extracts and determined the changes in morphology and proliferation of human keratinocytes and fibroblasts. All smokeless tobaccos stimulated keratinocyte proliferation at low doses (0.25% w/v) and suppressed growth at higher doses (> 0.5% w/v). In contrast, smokeless tobacco extracts promoted fibroblast growth at all concentrations without inducing fibroblast turnover. Fibroblasts and keratinocytes, therefore, were differentially affected by smokeless tobacco extracts in an organotypic tissue model, suggesting incipient changes that may occur in vivo.
Andersson G., Axell T. (1989). Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study. J Oral Pathol Med18:2-7.
2.
Axell T., Momstad H., Sundstrom B. (1976). The relation of the clinical picture to the histopathology of snuff dipper's lesions in a Swedish population. J Oral Pathol5:229-236.
3.
Daniels TE, Hansen LS, Greenspan JS, Grady DG, Hauck WW, Greene JC, et al. (1992). Histopathology of smokeless tobacco lesions in professional baseball players. Associations with different types of tobacco . Oral Surg Oral Med Oral Pathol Oral Radiol Endod73:720-725.
4.
Davis HM (1997). Smokeless tobacco research products. Louisville: The University of Kentucky Printing Services , pp. 1-12.
5.
Frithiof L., Anneroth G., Larsson U., Soderholm C. (1983). The snuff-induced lesion. A clinical and morphological study of a Swedish material. Acta Odontol Scand41:53-64.
6.
Hirsch JM, Heyden G., Thilander H. (1982). A clinical, histomorphological and histochemical study on snuff-induced lesions of varying severity. J Oral Pathol11:387-398.
7.
Hoffmann D., Djordjevic MV (1997). Chemical composition and carcinogenicity of smokeless tobacco. Adv Dent Res11:322-329.
8.
Ibrahim SO, Bertelsen B., Kalvenes MB, Idris AM, Vasstrand EN, Nilsen R., et al. (1998). Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. APMIS106:959-969.
9.
Idris AM, Warnakulasuriya KA, Ibrahim YE, Hartley R., Paterson K., Patel B., et al. (1998). Characterization of an amorphous deposit in the lamina propria in oral snuff users in the Sudan as collagen. J Oral Pathol Med27:157-162.
10.
Johnson GK, Poore TK, Squier CA, Wertz PW, Reinhardt RA, Vincent SD (1994). Prostaglandin E2 and interleukin-1 levels in smokeless tobacco-induced oral mucosal lesions. J Periodontal Res29:430-438.
11.
Johnson GK, Poore TK, Payne JB, Organ CC (1996). Effect of smokeless tobacco extract on human gingival keratinocyte levels of prostaglandin E2 and interleukin-1. J Periodontol67:116-124.
12.
Karen J., Wang Y., Javaherian A., Vaccariello M., Fusenig NE, Garlick JA (1999). 12-O-tetradecanoylphorbol-13-acetate induces clonal expansion of potentially malignant keratinocytes in a tissue model of early neoplastic progression. Cancer Res59:474-481.
13.
Kaugars GE, Riley WT, Brandt RB, Burns JC, Svirsky JA (1992). The prevalence of oral lesions in smokeless tobacco users and an evaluation of risk factors. Cancer70:2579-2585.
14.
Muns G., Vishwanatha JK, Rubinstein I. (1994). Effects of smokeless tobacco on chemically transformed hamster oral keratinocytes: role of angiotensin I-converting enzyme. Carcinogenesis15:1325-1327.
15.
Murrah VA, Gilchrist EP, Moyer MP (1993). Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod75:323-332.
16.
Nilsson R. (1998). A qualitative and quantitative risk assessment of snuff dipping. Regul Toxicol Pharmacol28:1-16 [published erratum appears in Regul Toxicol Pharmacol29 :97, 1999].
17.
Parenteau NL (1994). Skin equivalents. In: The keratinocyte handbook. Leigh IM, Watt FM, editors. Cambridge, UK: Cambridge University Press, pp. 45-56.
18.
Payne JB, Johnson GK, Reinhardt RA, Schmid M. (1998). Histological alterations following short-term smokeless tobacco exposure in humans. J Periodontal Res33:274-279.
19.
Rheinwald JG, Green H. (1975). Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinocyte colonies from single cells. Cell6:331-344.
20.
Ringdahl BE, Johnson GK, Ali RB, Organ CC (1997). Effect of nicotine on arachidonic acid metabolites and epithelial parameters in rat oral mucosa. J Oral Pathol Med26:40-45.
21.
Vaccariello M., Javaherian A., Garlick JA (1999). A skin substitute model for wound healing. In: Bioengineering of skin substitutes. Morgan J, Yarmush ML, editors. Totowa, NJ: Humana Press, pp. 391-406.
22.
Wu Y-J., Parker LM, Binder NE, Beckett MA, Sinard JH, Griffiths CT, et al. (1982). The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells nonkeratinizing epithelia. Cell31 :693-703.
